Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
This article presents a three-year experience with mTOR inhibitors in the schemes of immunosuppressive therapy in patients post liver transplantation.
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2016-01-01
|
| Series: | Трансплантология (Москва) |
| Subjects: | |
| Online Access: | https://www.jtransplantologiya.ru/jour/article/view/13 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850041594742308864 |
|---|---|
| author | M. Sh Khubutia V. E. Sjutkin N. K. Kuznetsova S. V. Zhuravel M. S. Novruzbekov |
| author_facet | M. Sh Khubutia V. E. Sjutkin N. K. Kuznetsova S. V. Zhuravel M. S. Novruzbekov |
| author_sort | M. Sh Khubutia |
| collection | DOAJ |
| description | This article presents a three-year experience with mTOR inhibitors in the schemes of immunosuppressive therapy in patients post liver transplantation. |
| format | Article |
| id | doaj-art-5d54f68c099b4d53b6a503de0c16d69b |
| institution | DOAJ |
| issn | 2074-0506 2542-0909 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department |
| record_format | Article |
| series | Трансплантология (Москва) |
| spelling | doaj-art-5d54f68c099b4d53b6a503de0c16d69b2025-08-20T02:55:45ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092016-01-0102232713Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipientsM. Sh Khubutia0V. E. Sjutkin1N. K. Kuznetsova2S. V. Zhuravel3M. S. Novruzbekov4Sklifosovsky Research Institute for Emergency Medicine, MoscowSklifosovsky Research Institute for Emergency Medicine, MoscowSklifosovsky Research Institute for Emergency Medicine, MoscowSklifosovsky Research Institute for Emergency Medicine, MoscowSklifosovsky Research Institute for Emergency Medicine, MoscowThis article presents a three-year experience with mTOR inhibitors in the schemes of immunosuppressive therapy in patients post liver transplantation.https://www.jtransplantologiya.ru/jour/article/view/13liver transplantationimmunosuppressive therapyinhibitors mtor |
| spellingShingle | M. Sh Khubutia V. E. Sjutkin N. K. Kuznetsova S. V. Zhuravel M. S. Novruzbekov Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients Трансплантология (Москва) liver transplantation immunosuppressive therapy inhibitors mtor |
| title | Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients |
| title_full | Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients |
| title_fullStr | Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients |
| title_full_unstemmed | Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients |
| title_short | Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients |
| title_sort | long term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients |
| topic | liver transplantation immunosuppressive therapy inhibitors mtor |
| url | https://www.jtransplantologiya.ru/jour/article/view/13 |
| work_keys_str_mv | AT mshkhubutia longtermuseofeverolimusasacomponentofimmunosuppressivetherapyinlivertransplantrecipients AT vesjutkin longtermuseofeverolimusasacomponentofimmunosuppressivetherapyinlivertransplantrecipients AT nkkuznetsova longtermuseofeverolimusasacomponentofimmunosuppressivetherapyinlivertransplantrecipients AT svzhuravel longtermuseofeverolimusasacomponentofimmunosuppressivetherapyinlivertransplantrecipients AT msnovruzbekov longtermuseofeverolimusasacomponentofimmunosuppressivetherapyinlivertransplantrecipients |